IP Library Granted Patent US 8,439,966
Granted Patent B1
US 8,439,966 · App. 13/728,431 · Granted May 14, 2013

Intravascular stent and method of use

Inventor: Timothy Limon (Cupertino, CA)
Assignee: Advanced Cardiovascular Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,439,966
App. No.
13/728,431
Granted
May 14, 2013
Kind
B1
Abstract

An expandable stent is implanted in a body lumen, such as a coronary artery, peripheral artery, or other body lumen for treating an area of vulnerable plaque. The invention provides for a an intravascular stent having a plurality of cylindrical rings connected by undulating links. The stent has a high degree of flexibility in the longitudinal direction, yet has adequate vessel wall coverage and radial strength sufficient to hold open an artery or other body lumen. A central section is positioned between distal and proximal sections and is aligned with the area of vulnerable plaque to enhance growth of endothelial cells over the fibrous cap of the vulnerable plaque to reinforce the area and reduce the likelihood of rupture.

Claims (11)

1. An intravascular stent for use in a body lumen, comprising:

a distal section, a proximal section, and a central section positioned between the distal section and the proximal section, each section being aligned along a common longitudinal axis forming the stent;

the distal section and the proximal section having cylindrical rings, wherein the distal section includes all cylindrical rings distal to the central section and the proximal section includes all cylindrical rings proximal to the central section and wherein all cylindrical rings in the distal and proximal section have a first longitudinal length, and the central section consisting of a single cylindrical ring having a second longitudinal length, the first longitudinal length being shorter than the second longitudinal length;

the distal section and the proximal section having a first strut pattern having a first radial thickness, and the central section having a second strut pattern having a second radial thickness that is less than the first radial thickness; and

the second strut pattern having a substantially uniform repeating series of struts that form the single cylindrical ring of the central section wherein each strut is directly attached to an adjacent strut to define a zig-zag pattern;

at least a portion of the central ring is provided with a cover.

2. The stent of claim 1 , wherein the cylindrical rings are interconnected by links.

3. The stent of claim 1 , wherein at least a portion of the distal section rings are coated with a therapeutic drug to reduce cell growth distal to the central section.

4. The stent of claim 1 , wherein at least a portion of the proximal section rings are coated with a therapeutic drug to reduce cell growth proximal to the central section.

5. The stent of claim 1 , wherein the first strut pattern is more radiopaque than the second strut pattern.

6. The stent of claim 1 , wherein the struts in the first strut pattern and the struts in the second strut pattern all have the same strut width.

Continuity (3)
Division 13533662 · Jun 26, 2012
Division 11641634 · Dec 19, 2006
Division 10034208 · Dec 28, 2001